Literature DB >> 27481559

Reactivity of the glutathione species towards the reduction of ormaplatin (or tetraplatin).

Jingran Dong1, Shuying Huo1, Shigang Shen1, Jianzhong Xu1, Tiesheng Shi2, Lars I Elding3.   

Abstract

The reduction of ormaplatin (tetraplatin), a prototype for Pt(IV) anticancer prodrugs, by glutathione (GSH) was kinetically characterized over a wide pH range at 25.0°C and 1.0M ionic strength. The reduction follows overall second-order kinetics, giving rise to the oxidized glutathione as the oxidation product, which was identified by high-resolution mass spectrometry. The reaction mechanism put forward involves parallel attacks by all the GSH species on the Pt(IV) prodrug as rate-determining steps. All rate constants for the rate-determining steps have been derived for the first time, enabling the construction of the reactivity of GSH species versus their pH distribution diagram. The diagram clearly displays that only one out of the five GSH species is the mainly responsible for the reduction of ormaplatin at the physiological pH of 7.4.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticancer; Glutathione; Kinetic analysis; Ormaplatin (tetraplatin); Reduction

Mesh:

Substances:

Year:  2016        PMID: 27481559     DOI: 10.1016/j.bmcl.2016.07.046

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Structure elucidation and quantification of the reduction products of anticancer Pt(iv) prodrugs by electrochemistry/mass spectrometry (EC-MS).

Authors:  L M Frensemeier; J Mayr; G Koellensperger; B K Keppler; C R Kowol; U Karst
Journal:  Analyst       Date:  2018-04-30       Impact factor: 4.616

2.  Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma.

Authors:  Yang Liu; Hongwu Tian; Liyao Xu; Li Zhou; Jinhu Wang; Benyan Xu; Chunli Liu; Lars I Elding; Tiesheng Shi
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.